Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.

18:42 07/09/2023

Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.

Sinolink: Continued effectiveness of carbon neutrality policies, with supply-side impacts gradually taking effect.

Orient: 2026 is the year of mass production of domestic super nodes, with continued growth in power consumption leading to increased demand for PSU, HVDC, and SST.

Behind the explosive performance of the simulation chip "king" Texas Instruments Incorporated (TXN.US): semiconductor recovery has spread AI computing power to industry and automotive sectors.

Sinolink: Continued effectiveness of carbon neutrality policies, with supply-side impacts gradually taking effect.

Orient: 2026 is the year of mass production of domestic super nodes, with continued growth in power consumption leading to increased demand for PSU, HVDC, and SST.

Behind the explosive performance of the simulation chip "king" Texas Instruments Incorporated (TXN.US): semiconductor recovery has spread AI computing power to industry and automotive sectors.